143 related articles for article (PubMed ID: 29138086)
1. Eugenol derivatives prospectively inhibit l-asparaginase: A heady target protein of Salmonella typhimurium.
Vimal A; Jha A; Kumar A
Microb Pathog; 2018 Jan; 114():8-16. PubMed ID: 29138086
[TBL] [Abstract][Full Text] [Related]
2. Degradation product of curcumin restrain
Vimal A; Siddiqui MH; Verma A; Kumar A
J Complement Integr Med; 2023 Jun; 20(2):413-424. PubMed ID: 34860475
[TBL] [Abstract][Full Text] [Related]
3. Eucalyptol, sabinene and cinnamaldehyde: potent inhibitors of salmonella target protein L-asparaginase.
Vimal A; Pal D; Tripathi T; Kumar A
3 Biotech; 2017 Aug; 7(4):258. PubMed ID: 28735432
[TBL] [Abstract][Full Text] [Related]
4. Natural phytocompounds physalin D, withaferin a and withanone target L-asparaginase of
Sharma D; Saini R; Mishra A
J Biomol Struct Dyn; 2023 Apr; 41(7):2645-2659. PubMed ID: 35132949
[TBL] [Abstract][Full Text] [Related]
5. Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.
Torres A; Luke JD; Kullas AL; Kapilashrami K; Botbol Y; Koller A; Tonge PJ; Chen EI; Macian F; van der Velden AW
J Leukoc Biol; 2016 Feb; 99(2):387-98. PubMed ID: 26497246
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
7. Molecular drilling to combat
Upadhyay A; Pal D; Kumar A
Expert Opin Ther Targets; 2024 Apr; 28(4):323-334. PubMed ID: 38639582
[TBL] [Abstract][Full Text] [Related]
8. In silico modelling and molecular dynamics simulation studies on L-Asparaginase isolated from bacterial endophyte of Ocimum tenuiflorum.
Pola M; Rajulapati SB; Potla Durthi C; Erva RR; Bhatia M
Enzyme Microb Technol; 2018 Oct; 117():32-40. PubMed ID: 30037549
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling, simulation and virtual screening of MurD ligase protein from Salmonella typhimurium LT2.
Samal HB; Das JK; Mahapatra RK; Suar M
J Pharmacol Toxicol Methods; 2015; 73():34-41. PubMed ID: 25841669
[TBL] [Abstract][Full Text] [Related]
10. L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence.
Kullas AL; McClelland M; Yang HJ; Tam JW; Torres A; Porwollik S; Mena P; McPhee JB; Bogomolnaya L; Andrews-Polymenis H; van der Velden AW
Cell Host Microbe; 2012 Dec; 12(6):791-8. PubMed ID: 23245323
[TBL] [Abstract][Full Text] [Related]
11. In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme l-asparaginase.
Vimal A; Kumar A
Enzyme Microb Technol; 2017 Mar; 98():9-17. PubMed ID: 28110669
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Effect of Eugenol and Probiotic
Song F; Liu J; Zhao W; Huang H; Hu D; Chen H; Zhang H; Chen W; Gu Z
Nutrients; 2020 May; 12(6):. PubMed ID: 32486242
[TBL] [Abstract][Full Text] [Related]
13. L-Asparaginase as a new molecular target against leishmaniasis: insights into the mechanism of action and structure-based inhibitor design.
Singh J; Srivastava A; Jha P; Sinha KK; Kundu B
Mol Biosyst; 2015 Jul; 11(7):1887-96. PubMed ID: 25893895
[TBL] [Abstract][Full Text] [Related]
14. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
Rasul HO; Aziz BK; Ghafour DD; Kivrak A
J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing: An approach to tackle drug resistance in S. typhimurium.
Balasundaram P; Veerappapillai S; Krishnamurthy S; Karuppasamy R
J Cell Biochem; 2018 Mar; 119(3):2818-2831. PubMed ID: 29058787
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking-based virtual screening, drug-likeness, and pharmacokinetic profiling of some anti-
Ameji PJ; Uzairu A; Shallangwa GA; Uba S
J Taibah Univ Med Sci; 2023 Dec; 18(6):1417-1431. PubMed ID: 38162870
[TBL] [Abstract][Full Text] [Related]
17. MurC ligase of multi-drug resistant Salmonella Typhi can be inhibited by novel Curcumin derivative: Evidence from molecular docking and dynamics simulations.
Debroy R; Ramaiah S
Int J Biochem Cell Biol; 2022 Oct; 151():106279. PubMed ID: 35985453
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking simulation, drug-likeness assessment, and pharmacokinetic study of some cephalosporin analogues against a penicillin-binding protein of Salmonella typhimurium.
Ameji PJ; Uzairu A; Shallangwa GA; Uba S
J Antibiot (Tokyo); 2023 Apr; 76(4):211-224. PubMed ID: 36755130
[TBL] [Abstract][Full Text] [Related]
20. Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.
Marathe SA; Kumar R; Ajitkumar P; Nagaraja V; Chakravortty D
J Antimicrob Chemother; 2013 Jan; 68(1):139-52. PubMed ID: 23070736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
